Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes
Clinical trial NCT01890122 · COMPLETED
Trial details
- NCT number
- NCT01890122
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-09-01
- Enrollment
- 647
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.